Healthy volunteers help uncover drug interaction secrets
NCT ID NCT07279233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a common seizure medicine, carbamazepine, changes the amount of mirdametinib in the blood. 36 healthy adults took both drugs by mouth. The goal was to understand how the body processes mirdametinib when taken with carbamazepine, which can help doctors decide on proper dosing in future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medpace
Cincinnati, Ohio, 45227, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates